NAFDAC Issues Urgent Recall of Deekins Amoxicillin Batch Over Adverse Reactions

By Onoja Baba, Nigeria

The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the immediate recall of a batch of Deekins Amoxycillin 500mg Capsules following reports of severe adverse reactions in patients.

The affected batch, identified by lot number 4C639001, was manufactured by Eco-med Pharma Ltd and marketed by DevineKings Pharmaceutical Ltd. The recall comes after a hospital reported three serious cases of adverse drug reactions linked to the batch, prompting swift action from NAFDAC to protect public health.

In a statement shared on Wednesday via its official X (formerly Twitter) account, NAFDAC highlighted the urgency of the situation, urging healthcare professionals and consumers to immediately stop using the affected batch.

The statement read, “NAFDAC is notifying the public of the recall of one batch of Deekins Amoxycillin 500mg Capsules, manufactured by Eco-med Pharma Ltd and marketed by DevineKings Pharmaceutical Ltd, with lot number 4C639001. This batch is recalled following reports of serious adverse drug reactions.”

Amoxicillin, a widely used penicillin antibiotic, is commonly prescribed for bacterial infections such as tonsillitis, bronchitis, sinusitis, pneumonia, and infections of the ear, nose, throat, skin, or urinary tract.

NAFDAC emphasized its commitment to safeguarding public health and encouraged individuals to report any cases of suspected substandard or falsified medicines.

“Healthcare professionals and consumers are advised to report any suspicion of substandard and falsified medicines to the nearest NAFDAC office, call 0800-162-3322, or send an email to sf.alert@nafdac.gov.ng,” the statement concluded.